Combination of hypertension and diabetes causes rapid retinal cell death

Article

The combination of diabetes and hypertension-potentiated retinal oxidative and inflammatory stress accelerates retinal cell death and acellular capillary formation.

The combination of diabetes and hypertension-potentiated retinal oxidative and inflammatory stress accelerates retinal cell death and acellular capillary formation, reveals a paper in Molecular Vision.

A team led by Dr A.B. El-Remessy, Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, Georgia, USA, compared spontaneously hypertensive rats (SHR) to the outcomes of SHR with streptozotocin-induced diabetes (SHR+D). All rats were followed for 6 or 10 weeks, with Wistar rats were used as controls.

After six week both hypertension alone and hypertension with diabetes induced a quicker retinal cell death, compared to the control rats. The increase was linked to increased activation of phosphorylated-Jun N-terminal kinase (pJNK), phosphorylated-Akt inhibition, plasma and retinal lipid peroxides and soluble intracellular adhesion molecule-1 (sICAM-1) levels.

After 10 weeks there was a similar pattern in retinal nitrotyrosine, nuclear factor kappaB p65, and tumor necrosis factor-α expression being linked to exacerbated pJNK activation and acellular capillaries formation.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.